Figure 2.Puerarin attenuates LPS-induced cardiac dysfunction in mice. (A) Echocardiography was conducted to evaluate the changed in cardiac function in each group. Quantification of (B) ejection fraction (EF%), (C) fractional shortening (FS%) and (D) heart rate in all groups. Data represent the mean ± SD. *P < 0.05 vs Control group; #P < 0.05 vs. LPS group; &P < 0.05 vs. LPS+Pue group.
